 Biocept Inc NASDAQ:BIOC said that it has started offering a single test that can detect and distinguish between SARS-CoV-2 and influenza, helping patients and caregivers determine appropriate treatment decisions. This new assay expands the companys coronavirus COVID-19 testing program, which began in June 2020 and has now received more than 670,000 samples for processing. 